Edwards Lifesciences (EW) Restructuring Costs (2010 - 2026)

Edwards Lifesciences' Restructuring Costs history runs 15 years deep, the most recent figure standing at $37.1 million for Q1 2026.

• In Q1 2026, Restructuring Costs rose 783.33% year-over-year to $37.1 million; the TTM figure through Mar 2026 stood at -$62.3 million (down 376.89% YoY), while the FY2025 annual figure was $13.1 million, down 67.57% from the prior year.
• Restructuring Costs was $37.1 million for Q1 2026 at Edwards Lifesciences, up from -$103.7 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $147.9 million in Q2 2023 to a low of -$103.7 million in Q4 2025.
• Historically, Restructuring Costs has averaged $14.5 million across 5 years, with a median of $7.1 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Restructuring Costs surged 2324.59% in 2023, then sank 1482.67% in 2025.
• A 5-year view of Restructuring Costs shows it stood at $49.9 million in 2022, then plunged by 80.16% to $9.9 million in 2023, then slipped by 24.24% to $7.5 million in 2024, then tumbled by 1482.67% to -$103.7 million in 2025, then jumped by 135.78% to $37.1 million in 2026.
• The last three Restructuring Costs figures came in at $37.1 million (Q1 2026), -$103.7 million (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.